<SEC-DOCUMENT>0000935836-25-000710.txt : 20251118
<SEC-HEADER>0000935836-25-000710.hdr.sgml : 20251118
<ACCEPTANCE-DATETIME>20251118175713
ACCESSION NUMBER:		0000935836-25-000710
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20251118
DATE AS OF CHANGE:		20251118

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Design Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001807120
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				823929248
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92462
		FILM NUMBER:		251496145

	BUSINESS ADDRESS:	
		STREET 1:		6005 HIDDEN VALLEY ROAD
		STREET 2:		SUITE 110
		CITY:			CARLSBAD
		STATE:			CA
		ZIP:			92011
		BUSINESS PHONE:		858-293-4900

	MAIL ADDRESS:	
		STREET 1:		6005 HIDDEN VALLEY ROAD
		STREET 2:		SUITE 110
		CITY:			CARLSBAD
		STATE:			CA
		ZIP:			92011

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Logos Global Management LP
		CENTRAL INDEX KEY:			0001792126
		ORGANIZATION NAME:           	
		EIN:				833997742
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		1 LETTERMAN DRIVE
		STREET 2:		BLDG C, SUITE C3-350
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94129
		BUSINESS PHONE:		4158014660

	MAIL ADDRESS:	
		STREET 1:		1 LETTERMAN DRIVE
		STREET 2:		BLDG C, SUITE C3-350
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94129
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <previousAccessionNumber>0000935836-25-000657</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: CIK/CCC not verified. User token is expired. -->
          <cik>0001792126</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>3</amendmentNo>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <dateOfEvent>11/14/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001807120</issuerCIK>
        <issuerCUSIP>25056L103</issuerCUSIP>
        <issuerName>Design Therapeutics, Inc.</issuerName>
        <address>
          <com:street1>6005 Hidden Valley Road</com:street1>
          <com:street2>Suite 110</com:street2>
          <com:city>Carlsbad</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92011</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Derek Gould</personName>
          <personPhoneNum>(415) 801-4660</personPhoneNum>
          <personAddress>
            <com:street1>One Letterman Drive, Building C</com:street1>
            <com:street2>Suite C3</com:street2>
            <com:city>San Francisco</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>94129</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001792126</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Logos Global Management LP</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2500000.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2500000.00</sharedDispositivePower>
        <aggregateAmountOwned>2500000.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>4.4</percentOfClass>
        <typeOfReportingPerson>IA</typeOfReportingPerson>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
        <commentContent>Percentage based on 56,963,757 shares of Common Stock outstanding as of October 31, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2025.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Logos Global Management GP LLC</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2500000.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2500000.00</sharedDispositivePower>
        <aggregateAmountOwned>2500000.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>4.4</percentOfClass>
        <typeOfReportingPerson>HC</typeOfReportingPerson>
        <typeOfReportingPerson>OO</typeOfReportingPerson>
        <commentContent>Percentage based on 56,963,757 shares of Common Stock outstanding as of October 31, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2025.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001831371</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Logos Global Master Fund LP</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>E9</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1500000.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1500000.00</sharedDispositivePower>
        <aggregateAmountOwned>1500000.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>2.6</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
        <commentContent>Percentage based on 56,963,757 shares of Common Stock outstanding as of October 31, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2025.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Logos GP LLC</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1500000.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1500000.00</sharedDispositivePower>
        <aggregateAmountOwned>1500000.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>2.6</percentOfClass>
        <typeOfReportingPerson>HC</typeOfReportingPerson>
        <typeOfReportingPerson>OO</typeOfReportingPerson>
        <commentContent>Percentage based on 56,963,757 shares of Common Stock outstanding as of October 31, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2025.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001848372</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Arsani William</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>15000.00</soleVotingPower>
        <sharedVotingPower>2500000.00</sharedVotingPower>
        <soleDispositivePower>15000.00</soleDispositivePower>
        <sharedDispositivePower>2500000.00</sharedDispositivePower>
        <aggregateAmountOwned>2515000.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>4.4</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <typeOfReportingPerson>HC</typeOfReportingPerson>
        <commentContent>Percentage based on 56,963,757 shares of Common Stock outstanding as of October 31, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2025.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock</securityTitle>
        <issuerName>Design Therapeutics, Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>6005 Hidden Valley Road</com:street1>
          <com:street2>Suite 110</com:street2>
          <com:city>Carlsbad</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92011</com:zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item2>
        <filingPersonName>The reporting persons are:

Logos Global Management LP, a Delaware limited partnership ("Logos Global")

Logos Global Management GP LLC, a Delaware limited liability company ("Logos Global GP")

Logos Global Master Fund LP, a Cayman Island limited partnership ("Global Fund")

Logos GP LLC, a Delaware limited liability company ("Logos GP")

Arsani William

The reporting persons are filing this statement jointly but not as members of a group, and they expressly disclaim membership in a group.  Each reporting person disclaims beneficial ownership of Stock except to the extent of that person's pecuniary interest therein.</filingPersonName>
        <principalBusinessAddress>One Letterman Drive, Building C, Suite C3-350, San Francisco, California 94129.</principalBusinessAddress>
        <principalJob>Logos Global is the investment adviser to several private funds, including Global Fund (collectively, the "Funds").  Logos Global GP is the general partner of Logos Global.  Logos GP is the general partner of Global Fund. Dr. William is the control person of Logos Global, Logos Global GP and Logos GP and the portfolio manager of Global Fund.</principalJob>
        <hasBeenConvicted>During the last five years, none of the reporting persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>During the last five years, none of the reporting persons was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</convictionDescription>
        <citizenship>For citizenship of the reporting persons, see Item 6 of each reporting person's cover page.</citizenship>
      </item2>
      <item3>
        <fundsSource>Certain of the Funds acquired 1,217,627 shares of the Stock as a result of the automatic conversion of shares of Preferred Stock of the Issuer immediately prior to the completion of the Issuer's initial public offering on March 30, 2021. No additional consideration was paid for those shares of Stock.

Dr. William was granted options to acquire 15,000 shares of the Stock for his services as a director.

The shares of Stock held by Global Fund were acquired for a total purchase price of $3,887,563.90.

The Funds used their working capital to make the foregoing purchases.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>The reporting persons filed this Schedule 13D because Dr. William was on the Issuer' board of directors.  Dr. William resigned from the Issuer's board of directors on September 9, 2025.  The reporting persons will routinely monitor the Issuer regarding a wide variety of factors that affect their investment considerations, including, current and anticipated future trading prices of the Stock and other securities, the Issuer's operations, assets, prospects, financial position, and business development, Issuer's management, Issuer-related competitive and strategic matters, general economic, financial market and industry conditions, and other investment considerations.  Depending on their evaluation of various factors, the reporting persons may take such actions regarding their holdings of the Issuer's securities as they deem appropriate in light of circumstances existing from time to time. Such actions may include purchasing additional securities in the open market, through privately negotiated transactions with third parties or otherwise, and selling at any time, in the open market, through privately negotiated transactions with third parties or otherwise, all or part of the securities now owned or hereafter acquired by any of them.  The reporting persons also may from time to time enter into or unwind hedging or other derivative transactions with respect to the Stock or pledge their interests in the Stock to obtain liquidity. In addition, from time to time the reporting persons and their representatives and advisers may communicate with other stockholders, industry participants and other interested parties about the Issuer.

The reporting persons have no present plan or proposal that relates to or would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D of the Act.  However, the reporting persons may recommend additional actions to the Issuer's management, board of directors and stockholders. Any such actions could involve one or more of the events referred to in clauses (a) through (j) of Item 4 of Schedule 13D, including, potentially, one or more mergers, consolidations, sales or acquisitions of assets, change in control, issuances, purchases, dispositions or pledges of securities or other changes in capitalization.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>Aggregate number of shares beneficially owned by the reporting persons:

Logos Global: 2,500,000

Logos Global GP: 2,500,000

Global Fund: 1,500,000

Logos GP: 1,500,000

Arsani William: 2,515,000

Aggregate percentage of the class of Stock beneficially owned by the reporting persons:

Logos Global: 4.4%

Logos Global GP: 4.4%

Global Fund: 2.6%

Logos GP: 2.6%

Arsani William: 4.4%</percentageOfClassSecurities>
        <numberOfShares>Number of shares as to which the each reporting person has:

(i)  Sole power to vote or to direct the vote:

Logos Global: 0

Logos Global GP: 0

Global Fund: 0

Logos GP: 0

Arsani William: 15,000

(ii)  Shared power to vote or to direct the vote:?

Logos Global: 2,500,000

Logos Global GP: 2,500,000

Global Fund: 1,500,000

Logos GP: 1,500,000

Arsani William: 2,500,000

(iii)  Sole power to dispose or to direct the disposition of:

Logos Global: 0

Logos Global GP: 0

Global Fund: 0

Logos GP: 0

Arsani William: 15,000

(iv)  Shared power to dispose or to direct the disposition of:?

Logos Global: 2,500,000

Logos Global GP: 2,500,000

Global Fund: 1,500,000

Logos GP: 1,500,000

Arsani William: 2,500,000</numberOfShares>
        <transactionDesc>The reporting persons engaged in the transactions set forth on Exhibit 99.2 in the Issuer's Common Stock in the 60 days preceding the date of this Schedule 13D. All transactions were effectuated in the open market through a broker.</transactionDesc>
        <listOfShareholders>Not applicable.</listOfShareholders>
        <date5PercentOwnership>Not applicable.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>Logos Global is the investment adviser to its clients pursuant to investment management agreements or limited partnership agreements providing to Logos Global the authority, among other things, to invest the funds of such clients in Stock, to vote and dispose of Stock and to file this statement on behalf of such clients. Pursuant to such limited partnership agreements, Logos Global and its affiliates are entitled to allocations based on assets under management and realized and unrealized gains.  Pursuant to such investment management agreements, Logos Global is entitled to fees based on assets under management and realized and unrealized gains.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Exhibit 99.1     Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G.

Exhibit 99.2      Transactions in the Past 60 Days</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Logos Global Management LP</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Arsani William</signature>
          <title>Managing Partner</title>
          <date>11/18/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Logos Global Management GP LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Arsani William</signature>
          <title>Managing Member</title>
          <date>11/18/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Logos Global Master Fund LP</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Arsani William</signature>
          <title>Managing Member of Logos GP LLC, General Partner of Logos Global Master Fund LP</title>
          <date>11/12/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Logos GP LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Arsani William</signature>
          <title>Managing Member</title>
          <date>11/12/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Arsani William</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Arsani William</signature>
          <title>Self Reporting</title>
          <date>11/18/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>ex9920251112.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #EE0000">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #EE0000">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">EXHIBIT A</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">AGREEMENT REGARDING JOINT FILING</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">OF STATEMENT ON SCHEDULE 13D OR 13G</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The undersigned agree to file jointly with the Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) any and all statements on Schedule 13D or Schedule 13G or Forms 3, 4 or 5(and any amendments
or supplements thereto) required under section 13(d) and 16(a) of the Securities Exchange Act of 1934, as amended, in connection with
purchases by the undersigned of the securities of any issuer. For that purpose, the undersigned hereby constitute and appoint Logos Global
Management LP, a Delaware limited partnership, as their true and lawful agent and attorney-in-fact, with full power and authority for
and on behalf of the undersigned to prepare or cause to be prepared, sign, file with the SEC and furnish to any other person all certificates,
instruments, agreements and documents necessary to comply with section 13(d) and section 16(a) of the Securities Exchange Act of 1934,
as amended, in connection with said purchases, and to do and perform every act necessary and proper to be done incident to the exercise
of the foregoing power, as fully as the undersigned might or could do if personally present.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Dated:&#9;November 18, 2025</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #EE0000">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>Logos Global Management LP</B></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Signature: <U>/s/ <I>Arsani William</I>&#9;&#9;&#9;<BR>
    </U>Name/Title: Managing Partner</P></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>Logos Global Master Fund LP</B></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Signature: <U>/s/ <I>Arsani William&#9;&#9;&#9;</I><BR>
    </U>Name/Title: Managing Member of Logos GP LLC, General Partner of Logos Global Master Fund LP</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>Logos Global Management GP LLC</B></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Signature: <U>/s/ <I>Arsani William&#9;&#9;&#9;</I><BR>
    </U>Name/Title: Managing Member</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>Logos GP LLC</B></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Signature: <U>/s/ <I>Arsani William</I>&#9;&#9;&#9;<BR>
    </U>Name/Title: Managing Member</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><U>/s/ <I>Arsani William</I>&#9;&#9;&#9;&#9;</U><B><BR>
    Arsani William</B></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  </TABLE>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>dsgn_trans.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">EXHIBIT 99.2</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">TRANSACTIONS IN THE PAST 60 DAYS</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The reporting persons engaged in the following open
market transactions in the Issuer&rsquo;s Common Stock in the 60 days preceding the filing of this Schedule 13D.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 17%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Date</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD>
    <TD STYLE="width: 31%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Fund</FONT></TD>
    <TD STYLE="width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Purchase or Sale</FONT></TD>
    <TD STYLE="width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Number of Shares </FONT></TD>
    <TD STYLE="width: 16%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Price per Share</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">11/14/2025</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Logos Global Master Fund, L.P.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Sale</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(620,000)</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$7.25</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">11/18/2025</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Logos Global Master Fund, L.P.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Sale</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(120,000)</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$7.5035</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
